Effects of Ginkgo biloba in dementia: systematic review and meta-analysis

[21] Raschetti R(1997)The Neuropsychiatric Inventory: assessing psychopathology in dementia patients Neurology 48 S10-iv

[22] Albanese E(2002)Assessing quality of life in older adults with cognitive impairment Psychosom Med 64 510-554

[23] Vanacore N(2005)Measurement of health-related quality of life for people with dementia: development of a new instrument (DEMQOL) and an evaluation of current methodology Health Technol Assess 9 1-303

[24] Maggini M(1989)Measurement of quality-of-life changes in patients with Alzheimer's disease Clin Ther 11 545-1332

[25] Snowdon DA(2003)Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial Pharmacopsychiatry 36 297-655

[26] Greiner LH(1997)A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group[see comment] JAMA 278 1327-11

[27] Mortimer JA(1997)Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type J Psychiatr Res 31 645-551

[28] Riley KP(2007)Ginkgo biloba special extract in dementia with neuropsychiatric features. A randomised, placebo-controlled, double-blind clinical trial Arzneimittelforschung 57 4-1194

[29] Greiner PA(2005)A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type[see comment] Curr Alzheimer Res 2 541-190

[30] Markesbery WR(2000)The efficacy of ginkgo for elderly people with dementia and age-associated memory impairment: new results of a randomized clinical trial J Am Geriatr Soc 48 1183-56

[21] Raschetti R(1997)The Neuropsychiatric Inventory: assessing psychopathology in dementia patients Neurology 48 S10-iv

[22] Albanese E(2002)Assessing quality of life in older adults with cognitive impairment Psychosom Med 64 510-554

[23] Vanacore N(2005)Measurement of health-related quality of life for people with dementia: development of a new instrument (DEMQOL) and an evaluation of current methodology Health Technol Assess 9 1-303

[24] Maggini M(1989)Measurement of quality-of-life changes in patients with Alzheimer's disease Clin Ther 11 545-1332

[25] Snowdon DA(2003)Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial Pharmacopsychiatry 36 297-655

[26] Greiner LH(1997)A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group[see comment] JAMA 278 1327-11

[27] Mortimer JA(1997)Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type J Psychiatr Res 31 645-551

[28] Riley KP(2007)Ginkgo biloba special extract in dementia with neuropsychiatric features. A randomised, placebo-controlled, double-blind clinical trial Arzneimittelforschung 57 4-1194

[29] Greiner PA(2005)A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type[see comment] Curr Alzheimer Res 2 541-190

[30] Markesbery WR(2000)The efficacy of ginkgo for elderly people with dementia and age-associated memory impairment: new results of a randomized clinical trial J Am Geriatr Soc 48 1183-56